Hydrochloric Acid → 6-Methoxy-5-chloro-1-(4-piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one hydrochloride
反応式
[CH3:1][O:2][C:3]1[C:4]([Cl:26])=[CH:5][C:6]2[NH:10][C:9](=[O:11])[N:8]([CH:12]3[CH2:17][CH2:16][N:15](C(OC(C)(C)C)=O)[CH2:14][CH2:13]3)[C:7]=2[CH:25]=1.Cl>C(O)C>[ClH:26].[CH3:1][O:2][C:3]1[C:4]([Cl:26])=[CH:5][C:6]2[NH:10][C:9](=[O:11])[N:8]([CH:12]3[CH2:13][CH2:14][NH:15][CH2:16][CH2:17]3)[C:7]=2[CH:25]=1参加物
4
実験手順
1,1-Dimethylethyl 4-(6-methoxy-5-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-piperidinecarboxylate (D49) (35 mg) was dissolved in ethanol (1 ml) and HCl (4M in 1,4-dioxane, 1 ml) was added at room temperature. The mixture was stirred at room temperature for 4 h then evaporated to give the title compound, 30 mg.
後処理
- customthen evaporated
出典と根拠
- ORDレコード
- ord-96fe46227fe342539a1d4135c86d4595
- 出典データセット
- uspto-grants-2012_10
- 特許番号
- US08288412B2
反応ノート
読み込み中…